Elevate

Group CEO Dr. Tarek Moharram leads Elevate, as stated on the firm's website. While specific investment committee members are not disclosed, the team page lists additional professionals including Bassel Chanaa, Shady Diab, and Mohamed Moharram. The firm's small team structure suggests investment decisions are centralized under the Group CEO and the core team in Giza.

Elevate operates as a healthcare operator investment platform, acquiring and actively managing private healthcare businesses in Egypt and across Africa. The firm seeks to generate returns by applying a post-integration value creation playbook that unlocks vertical and horizontal synergies among its portfolio companies. The strategy also extends to education and financial services as adjacent social sectors, though the primary focus remains healthcare.

Based on its public disclosures, Elevate focuses on direct, control-oriented investments in operating companies. The firm describes itself as an operator investment platform with a dedicated post-integration team, which is characteristic of a direct investment approach. There is no indication that the firm makes commitments to external private equity funds.

Elevate does not explicitly publish a list of excluded sectors. However, its public-facing materials consistently describe a mandate centered on healthcare, with secondary interests in education and financial services. This suggests the firm is likely to avoid sectors far outside its social-impact and operator-competency zones, such as heavy industry or extractive resources.

Elevate's website states its mission is to create both financial and impactful returns, specifically to ameliorate the lives of underserved communities and enrich the standards of social sector industries. While it does not describe a legally separate philanthropic entity, the firm integrates ESG considerations and an impact mandate into its core investment process.